1. Home
  2. ATOS vs JRSH Comparison

ATOS vs JRSH Comparison

Compare ATOS & JRSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Atossa Therapeutics Inc.

ATOS

Atossa Therapeutics Inc.

HOLD

Current Price

$2.28

Market Cap

36.2M

Sector

Health Care

ML Signal

HOLD

Logo Jerash Holdings (US) Inc.

JRSH

Jerash Holdings (US) Inc.

HOLD

Current Price

$4.68

Market Cap

41.9M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATOS
JRSH
Founded
2009
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Apparel
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
36.2M
41.9M
IPO Year
2010
2017

Fundamental Metrics

Financial Performance
Metric
ATOS
JRSH
Price
$2.28
$4.68
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
2
Target Price
$23.00
$4.00
AVG Volume (30 Days)
133.7K
87.3K
Earning Date
05-13-2026
02-09-2026
Dividend Yield
N/A
5.68%
EPS Growth
N/A
485.71
EPS
N/A
0.27
Revenue
$1,758.00
$166,263,870.00
Revenue This Year
N/A
$11.64
Revenue Next Year
N/A
$10.06
P/E Ratio
N/A
$17.26
Revenue Growth
N/A
14.03
52 Week Low
$0.53
$2.85
52 Week High
$7.56
$5.47

Technical Indicators

Market Signals
Indicator
ATOS
JRSH
Relative Strength Index (RSI) 39.28 56.63
Support Level $0.58 $3.04
Resistance Level $2.60 $4.86
Average True Range (ATR) 0.19 0.20
MACD 0.09 -0.04
Stochastic Oscillator 26.83 61.70

Price Performance

Historical Comparison
ATOS
JRSH

About ATOS Atossa Therapeutics Inc.

Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.

About JRSH Jerash Holdings (US) Inc.

Jerash Holdings (US) Inc along with its subsidiaries, is a manufacturer and exporter of customized, ready-made sport and outerwear from knitted fabric from its production facilities in Jordan. The company manufactures for retailers, including Walmart, Costco, Sears, Hanes, Columbia, Land's End, VF Corporation, and Philip-Van Heusen, which owns brands such as The North Face, Nautica, Timberland, Wrangler, Lee, Jansport, Calvin Klein, Tommy Hilfiger, IZOD, and Speedo. It derives its revenue from the manufacturing and sales of outerwear in the United States. The company's product offering consists of jackets, polo shirts, crew neck shirts, pants, and shorts made from knitted fabric. Geographically, the company generates maximum revenue from the United States.

Share on Social Networks: